Ebony discusses the different treatments she has tried for alopecia areata and the providers that she consulted.
It’s almost immune to it if that makes sense, but those were some of the things that I’ve dealt with on these medications. Some of the challenges I’ve had with the medications are that I’d notice a lot of flare-ups within my immune system. It was a little hard to adjust to considering the adverse effects and things of that nature.
Despite decreasing trends observed in the global burden of alopecia areata, low-income countries and Western Sub-Saharan Africa regions continue to ...
The regions with the greatest changes in the incidence of AA were Central Sub-Saharan Africa and Western Sub-Saharan Africa. The 3 countries with the largest increases in AA incidence from 1990 to 2019 were Kuwait (EAPC, 0.15), South Sudan (EAPC, 0.12), and Nigeria (EAPC, 0.11). AA affects 2% of the general population and is a significant driver of psychological disorders such as depression, anxiety, and mental health distress. Contrary to global trends, the largest increases in the age-standardized incidence rate and age-standardized DALY rate of AA from 1990 to 2019 were observed in countries in the low-SDI quintile (EAPC, 0.02; 95% CI, −0.01 to 0.06; EAPC, 0.04; 95% CI, 0.03 to 0.04; respectively) and Western Sub-Saharan Africa regions. In assessing global AA data from 1990 to 2019, incidence increased 49.14% from 21,742,836.45 to 32,426,829.18, and the related number of DALYs increased from 401,682.16 to 600,570.37, an increase of 49.51%. Moreover, the global age-standardized incidence rate decreased (EAPC, −0.13; 95% CI, −0.13 to −0.12) and the age-standardized DALY rate showed a downward trend (EAPC, −0.12; 95% CI, −0.13 to −0.11). Seeking to provide comprehensive and comparable information on the burden of AA, they analyzed the global, regional, and national incidence and disability-adjusted life-years (DALYs) data from the Global Burden of Disease (GBD) 2019 study in terms of counts and age-standardized rates by sex, age, and sociodemographic index (SDI) value. Decreasing trends in the global burden of alopecia areata (AA) have been observed except in low-income countries and Western Sub-Saharan Africa regions, according to study findings published in Frontiers in Immunology.